RecruitingPhase 2NCT07127718

Preventive Strategies for Early and Late Complications of Leptospirosis

Studying Leptospirosis

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: National Kidney and Transplant Institute, Philippines
Principal Investigator: Romina A Danguilan, MD
National Kidney and Transplant Institute, Philippines
Intervention: Prophylactic Plasma Transfusion(biological)
Enrollment: 678 target
Eligibility: 18-60 years · All sexes
Timeline: 2024 – 2026

Study locations (3)

Institute of Human Genetics, National Institutes of Health - University of the Philippines Manila, Manila, National Capital Region, Philippines
San Lazaro Hospital, Manila, National Capital Region, Philippines
National Kidney and Transplant Institute, Quezon City, National Capital Region, Philippines

Collaborators

San Lazaro Hospital, Philippines · Institute of Human Genetics, National Institutes of Health - University of the Philippines Manila, Philippines · Department of Science and Technology, Philippines

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07127718 on ClinicalTrials.gov

Other trials for Leptospirosis

Additional recruiting or active studies for the same condition.

See all trials for Leptospirosis →

← Back to all trials